Because we have shown here that TJs also form a barrier in human HFs and therefore contribute to overall barrier function of the skin we wanted to check whether Cldn-1 is also affected in HFs of lesional or non-lesional skin from AD patients compared to healthy control skin. Here, CLDN1 is linked to Alzheimer disease.